Skip to content

Transversus abdominis plane block with liposomal bupivacaine for postoperative recovery quality in patients undergoing cesarean section: a randomized controlled study

Transversus abdominis plane block with liposomal bupivacaine for postoperative recovery quality in patients undergoing cesarean section

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080423
Enrollment
Unknown
Registered
2024-01-29
Start date
2024-02-05
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative recovery quality

Interventions

liposomal bupivacaine combined with bupivacaine hydrochloride:Transversus abdominis plane block with liposomal bupivacaine combined with bupivacaine hydrochloride
bupivacaine hydrochloride:Transversus abdominis plane block with bupivacaine hydrochloride

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. Age = 18 years old; 2. Full term pregnancy (37-42 weeks of gestation); 3. ASA level I-II; 4. Patients who plan to undergo cesarean section under spinal anesthesia.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. Refuse to sign the informed consent form; 2. There are relative contraindications to spinal anesthesia; 3. Allergies to research drugs; 4. Severe liver and kidney dysfunction; 5. Has a history of serious mental illness or other illnesses that cannot be evaluated or tested; 6. Insufficient pain relief during surgery, requiring remedial pain relief; 7. Refuse to use intravenous analgesia pump.

Design outcomes

Primary

MeasureTime frame
Postoperative recovery quality (QoR-15);

Secondary

MeasureTime frame
Postoperative recovery quality (QoR-15);Pain score on rest and movement;First rescue analgesia time;The frequency of remedial analgesia;Consumption of opioids;Side effects;Patient satisfaction with pain relief;Other;

Countries

China

Contacts

Public ContactJianjun Yang

The First Affiliated Hospital of Zhengzhou University

yjyangjj@126.com+86 137 8353 7619

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026